Bafiertam (Monomethyl fumarate) for Multiple Sclerosis

Overview
Bafiertam is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting MS, and secondary progressive MS. Bafiertam is also referred to by its drug name, monomethyl fumarate.

Bafiertam is a member of a class of drugs called fumaric acid derivatives. The exact way Bafiertam works is unknown. Bafiertam is believed to work by reducing inflammation and protecting body cells.

How do I take it?
Prescribing information states that Bafiertam is given orally twice per day.

Bafiertam comes as a delayed-release capsule.

Side effects
The FDA-approved label for Bafiertam lists common side effects including flushing, abdominal pain, diarrhea, and nausea.

Rare but serious side effects listed for Bafiertam include severe allergic reactions, serious infections including a rare brain infection called progressive multifocal leukoencephalopathy (PML), low white blood cell count, and liver damage.

For more details about this treatment, visit:

Bafiertam (Monomethyl Fumarate) — Banner Life Sciences
https://www.bafiertam.com